JSM2023
Back to the program
Roundtables – Lunch

Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee)

Mon, Aug 7, 12:30 PM

3 Presentations

ML05: Leveraging External Data to Augment or Serve as Control Arm in Rare Disease Studies
12:30 PM - 1:50 PM
Co-authors: Qi Zhang
ML06: Are We Ready to Tackle the Health Technology Assessment (HTA) Hurdle Beyond Regulatory Approval?
12:30 PM - 1:50 PM
Co-authors: Lara Wolfson (MSD), Shahrul Mt-Isa (Merck Sharp & Dohme), Weili He (AbbVie), Hongwei Wang (AbbVie)
ML07: Statistical Methods for Neurodegenerative Diseases
12:30 PM - 1:50 PM
Co-authors: Jessie Nicodemus-Johnson (Pentara), Suzanne Hendrix (Pentara Corporation), Newman Knowlton (Pentara Corporation), Mitchell Wassom (Pentara Corporation), Kent Hendrix (Pentara Corporation), Craig Mallinckrodt (Pentara Corp, Millcreek UT), Samuel Dickson (Pentara)
↑